On November 3, 2025, Draig Therapeutics announced the appointment of Ivana Magovčević-Liebisch as the President and Chief Executive Officer. She succeeds Ruth McKernan, who will remain on the board as a Non-executive Director.
Company Information
Company
Draig Therapeutics
Location
Cardiff, Wales, United Kingdom
About
Draig Therapeutics is a clinical-stage company focused on transforming the treatment of neuropsychiatric diseases through its innovative pipeline of next-generation therapies. The company targets core neurotransmission pathways that play a critical role in these complex disorders. Its lead candidate, DT-101, aims to provide more effective treatments for Major Depressive Disorder. Draig was formed through a collaboration with Cardiff University's Medicines Discovery Institute.
Fundz sees it the moment Draig Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CardiffBiotechnologyHealth CareTherapeuticsresearch